197 related articles for article (PubMed ID: 25340599)
1. Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate.
Boudechiche L; Tranchart H; Branchereau S; Davit-Spraul A; Laïnas P; Groyer-Picard MT; Weber A; Hadchouel M; Dagher I
Transplantation; 2015 Jan; 99(1):36-40. PubMed ID: 25340599
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide donor drugs improve the distribution and engraftment of transplanted hepatocytes in the liver.
Boudechiche L; Boutammine W; Meberouk-Boudechiche L; Lakhdara D
Acta Gastroenterol Belg; 2012 Jun; 75(2):234-9. PubMed ID: 22870789
[TBL] [Abstract][Full Text] [Related]
3. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis.
De Vree JM; Ottenhoff R; Bosma PJ; Smith AJ; Aten J; Oude Elferink RP
Gastroenterology; 2000 Dec; 119(6):1720-30. PubMed ID: 11113093
[TBL] [Abstract][Full Text] [Related]
4. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice.
Hoekstra H; Porte RJ; Tian Y; Jochum W; Stieger B; Moritz W; Slooff MJ; Graf R; Clavien PA
Hepatology; 2006 May; 43(5):1022-31. PubMed ID: 16628673
[TBL] [Abstract][Full Text] [Related]
5. Serum apolipoprotein E as a marker to monitor graft function after hepatocyte transplantation in a clinically relevant mouse model.
Jorns C; Takahashi T; Callaghan E; Zemack H; Larsson L; Nowak G; Parini P; Ericzon BG; Ellis E
Transplant Proc; 2013 Jun; 45(5):1780-6. PubMed ID: 23769043
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease.
Chen HL; Wang R; Chen HL; Hwu WL; Jeng YM; Chang MH; Ling V
J Biomed Sci; 2008 Sep; 15(5):615-22. PubMed ID: 18509747
[TBL] [Abstract][Full Text] [Related]
8. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases.
Vij M; Safwan M; Shanmugam NP; Rela M
Ann Diagn Pathol; 2015 Oct; 19(5):277-82. PubMed ID: 26117383
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
10. Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates.
Dagher I; Nguyen TH; Groyer-Picard MT; Lainas P; Mainot S; Guettier C; Pariente D; Franco D; Weber A
Hepatology; 2009 Mar; 49(3):950-9. PubMed ID: 19152424
[TBL] [Abstract][Full Text] [Related]
11. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.
Ikenaga N; Liu SB; Sverdlov DY; Yoshida S; Nasser I; Ke Q; Kang PM; Popov Y
Am J Pathol; 2015 Feb; 185(2):325-34. PubMed ID: 25478810
[TBL] [Abstract][Full Text] [Related]
12. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
13. Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization.
Dagher I; Boudechiche L; Branger J; Coulomb-Lhermine A; Parouchev A; Sentilhes L; Lin T; Groyer-Picard MT; Vons C; Hadchouel M; Pariente D; Andreoletti M; Franco D; Weber A
Transplantation; 2006 Oct; 82(8):1067-73. PubMed ID: 17060856
[TBL] [Abstract][Full Text] [Related]
14. Small animal models of hepatocyte transplantation.
Seppen J; Filali EE; Elferink RO
Methods Mol Biol; 2009; 481():75-82. PubMed ID: 19096792
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of the intrahepatic portal venous blood flow: impact on hepatocyte transplantation.
Timm F; Vollmar B
Microvasc Res; 2013 Mar; 86():34-41. PubMed ID: 23220352
[TBL] [Abstract][Full Text] [Related]
16. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.
Slehria S; Rajvanshi P; Ito Y; Sokhi RP; Bhargava KK; Palestro CJ; McCuskey RS; Gupta S
Hepatology; 2002 Jun; 35(6):1320-8. PubMed ID: 12029617
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation in progressive familial intrahepatic cholestasis III.
Chinnaratha MA; Venugopal K; de Boer WB; Macquillan G
Liver Int; 2013 Sep; 33(8):1293. PubMed ID: 23574360
[No Abstract] [Full Text] [Related]
18. Hepatic Stellate Cells Improve Engraftment of Human Primary Hepatocytes: A Preclinical Transplantation Study in an Animal Model.
Dusabineza AC; Najimi M; van Hul N; Legry V; Khuu DN; van Grunsven LA; Sokal E; Leclercq IA
Cell Transplant; 2015; 24(12):2557-71. PubMed ID: 25706818
[TBL] [Abstract][Full Text] [Related]
19. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.
Popov Y; Patsenker E; Fickert P; Trauner M; Schuppan D
J Hepatol; 2005 Dec; 43(6):1045-54. PubMed ID: 16223543
[TBL] [Abstract][Full Text] [Related]
20. Rat hepatocyte engraftment in severe combined immunodeficient x beige mice using mouse-specific anti-fas antibody.
Wilson JH; Paturzo FX; Johnson LK; Carreiro MP; Hixson DC; Mennone A; Boyer JL; Pober JS; Harding MJ
Xenotransplantation; 2006 Jan; 13(1):53-62. PubMed ID: 16497212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
